Numerous studies have indicated that KLF4 overexpression predicts a better prognosis in several malignancies, including prostate cancer, colon cancer, urothelial cancer and gastric cancer [14, 15, 40–41]. Here, KLF4 is linked to malignant colon neoplasm.